BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22804248)

  • 1. Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3 kinase/Akt signaling pathway.
    Kumar S; Patil HS; Sharma P; Kumar D; Dasari S; Puranik VG; Thulasiram HV; Kundu GC
    Curr Mol Med; 2012 Sep; 12(8):952-66. PubMed ID: 22804248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
    Yang T; Yao S; Zhang X; Guo Y
    Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway.
    Chen JH; Hsiao G; Lee AR; Wu CC; Yen MH
    Biochem Pharmacol; 2004 Apr; 67(7):1337-45. PubMed ID: 15013849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinase.
    Ji L; Liu T; Liu J; Chen Y; Wang Z
    Planta Med; 2007 Oct; 73(13):1397-401. PubMed ID: 17918040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway.
    Peng Y; Wang Y; Tang N; Sun D; Lan Y; Yu Z; Zhao X; Feng L; Zhang B; Jin L; Yu F; Ma X; Lv C
    J Exp Clin Cancer Res; 2018 Oct; 37(1):248. PubMed ID: 30314513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
    Mir H; Kapur N; Singh R; Sonpavde G; Lillard JW; Singh S
    Cell Cycle; 2016; 15(6):819-26. PubMed ID: 27029529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
    Tan XL; Guo L; Wang GH
    Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level.
    Zhao F; He EQ; Wang L; Liu K
    J Asian Nat Prod Res; 2008; 10(5-6):467-73. PubMed ID: 18464090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells.
    Hsieh MJ; Lin CW; Chiou HL; Yang SF; Chen MK
    Oncotarget; 2015 Oct; 6(31):30831-49. PubMed ID: 26356821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells.
    Li Y; Zhang P; Qiu F; Chen L; Miao C; Li J; Xiao W; Ma E
    Life Sci; 2012 Jun; 90(25-26):962-7. PubMed ID: 22634579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway.
    Kumar D; Haldar S; Gorain M; Kumar S; Mulani FA; Yadav AS; Miele L; Thulasiram HV; Kundu GC
    BMC Cancer; 2018 Jan; 18(1):52. PubMed ID: 29310608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway.
    Liang Y; Zhang Y; Wang G; Li Y; Huang W
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28098802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer.
    Islam MT; Ali ES; Uddin SJ; Islam MA; Shaw S; Khan IN; Saravi SSS; Ahmad S; Rehman S; Gupta VK; Găman MA; Găman AM; Yele S; Das AK; de Castro E Sousa JM; de Moura Dantas SMM; Rolim HML; de Carvalho Melo-Cavalcante AA; Mubarak MS; Yarla NS; Shilpi JA; Mishra SK; Atanasov AG; Kamal MA
    Cancer Lett; 2018 Apr; 420():129-145. PubMed ID: 29408515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer.
    Zhou X; Yue GG; Chan AM; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Biochem Pharmacol; 2017 Oct; 142():58-70. PubMed ID: 28669564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The altered microRNA profile in andrographolide-induced inhibition of hepatoma tumor growth.
    Lu B; Sheng Y; Zhang J; Zheng Z; Ji L
    Gene; 2016 Aug; 588(2):124-33. PubMed ID: 27182051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-κB-dependent matrix metalloproteinase-9 expression.
    Zhai Z; Qu X; Li H; Ouyang Z; Yan W; Liu G; Liu X; Fan Q; Tang T; Dai K; Qin A
    Mol Med Rep; 2015 Feb; 11(2):1139-45. PubMed ID: 25374279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis.
    Yang W; Zhao J; Wang Y; Xu H; Wu Z; Hu Y; Jiang K; Shen P; Ma C; Guan Z; Zhang Y; Ma J; Shang N; Yan G; Wang Z; Dai G
    Toxicol Appl Pharmacol; 2017 Jul; 327():1-12. PubMed ID: 28438631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.